Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes
Mariann I. Lassenius(Helsinki University Hospital), Matti Jauhiainen(Finnish Institute for Health and Welfare), Juha Kirveskari(University of Helsinki), Anmol Kumar(University of Helsinki), Carol Forsblom(University of Helsinki), Michaël Blaut(German Institute of Human Nutrition), Per‐Henrik Groop(University of Helsinki), Leena Riittinen(Helsinki University Hospital), Katri Haimila(Finnish Red Cross), Aila J. Ahola(University of Helsinki), Sulaiman R. Hamarneh(Harvard University), Daniel Gordin(Helsinki University Hospital), Christopher L. Fogarty(University of Helsinki), Taina Tervahartiala(Helsinki University Hospital), Markku Lehto(University of Helsinki), Richard A. Hodin(Massachusetts General Hospital), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Pirkko J. Pussinen(University of Helsinki), Annukka Paju(Helsinki University Hospital), Timo Sorsa(Helsinki University Hospital), Sohvi Hörkkö(University of Oulu), Mari‐Anne Härma(University of Helsinki), Juha Järvelä(University of Helsinki)
Cited by 66
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k